Microbot Medical Inc.

NASDAQ:MBOT

Medical - Instruments & Supplies

Healthcare
$0.98 -2.93%

-$0.06 today

Market cap
$65.73M
Beta
1.04
P/E (TTM)
-8.6
EPS (TTM)
-$0.21
52W Low $1.60High $4.67

Volume 0.87M

Average 1.60M

MBOT Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Microbot Medical Inc.NASDAQ: MBOT

Retained Earnings · Q1 FY2026 · quarter ended Mar 2026

Retained earnings remains negative

Q1 FY2026 retained earnings was -$107.76M, compared with -$93.55M a year earlier.

Context

  • Retained earnings amounted to 138.0% of total assets at the end of Q1 FY2026, down 164.8 pp from a year earlier.
  • Retained earnings grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -15.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$107.76M-3.5% QoQ
Last fiscal yearDec 2025
-$104.09M-14.5% YoY
Year agoMar 2025
-$93.55M-15.2% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-15.2%——
1 year-14.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
(104.09M) USD
Year-over-year change
-14.5%

Retained Earnings vs competitors

How MBOT compares with its peers on the latest reported figures

  • Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -15.2% is the 6th highest of 10, against a peer median of -12.1%.
  • Retained earnings amounts to 138.0% of total assets for MBOT, versus a peer median of 366.7%.
MBOT Competitors
Retained Earnings for MBOT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ORMPOramed Pharmaceuticals Inc.Mar 2026-$85.12M USD+53.8%—31.7%
ZTEKZentek Ltd.Mar 2026-CA$91.46M CAD-9.1%—604.7%
MBOTMicrobot Medical Inc.Mar 2026-$107.76M USD-15.2%—138.0%
CNTXContext Therapeutics Inc.Mar 2026-$139.58M USD-40.5%—237.1%
VANIVivani Medical, Inc.Mar 2026-$155.31M USD-21.1%—366.7%
DCGODocGo Inc.Mar 2026-$198.56M USD-1737.3%—94.9%
CRDLCardiol Therapeutics Inc.Mar 2026-CA$224.47M CAD-19.7%—712.9%
CLNNClene Inc.Mar 2026-$316.39M USD-11.8%—1460.4%
OVIDOvid Therapeutics Inc.Mar 2026-$338.7M USD-7.7%—150.1%
RCELAVITA Medical, Inc.Mar 2026-$419.01M USD-12.1%—812.9%
Peer median (excluding MBOT) —-12.1%—366.7%

Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents13.49M2.52M2.47M3.11M3.91M
Short-term Investments2M5.76M3.92M2.36M74.68M
Net Receivables174K103K1.49M300K241K
Inventory0000584K
Other Current Assets87K3K49K49K405K
Total Current Assets15.88M8.81M7.92M5.82M79.82M
Property, Plant & Equipment (Net)888K723K406K212K926K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0000796K
Total Non-current Assets888K723K406K212K1.72M
Total Assets16.77M9.54M8.33M6.03M81.54M
Account Payables279K116K357K165K511K
Short-term Debt0283K000
Tax Payables00000
Deferred Revenue000093K
Other Current Liabilities0298K804K1.41M1.98M
Total Current Liabilities1.98M2.07M3.79M2.46M3.42M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities402K179K40K41K569K
Total Liabilities2.39M2.25M3.83M2.5M3.99M
Common Stock72K80K118K195K672K
Retained Earnings(55.59M)(68.76M)(79.5M)(90.94M)(104.09M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity14.38M7.29M4.5M3.53M77.55M
Total Debt680K462K231K111K865K
Net Debt(12.81M)(2.06M)(2.24M)(3M)(3.05M)

Microbot Medical Inc.

NASDAQ:MBOT

Intrinsic Alpha fair value

Locked

Current Price

$0.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.